Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group

Introduction. Drooling in Parkinson’s disease (PD) is frequent but often goes underrecognized. Our aim was to examine the prevalence of drooling in a PD cohort and compare it with a control group. Specifically, we identified factors associated with drooling and conducted subanalyses in a subgroup of...

Full description

Saved in:
Bibliographic Details
Main Authors: Diego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, Maria J. Feal Painceiras, Maria Cristina Íñiguez-Alvarado, Silvia Jesús, Maria Teresa Buongiorno, Lluís Planellas, Marina Cosgaya, Juan García Caldentey, Nuria Caballol, Ines Legarda, Jorge Hernández Vara, Iria Cabo, Lydia López Manzanares, Isabel González Aramburu, Maria A. Ávila Rivera, Víctor Gómez Mayordomo, Víctor Nogueira, Víctor Puente, Julio Dotor García-Soto, Carmen Borrué, Berta Solano Vila, María Álvarez Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Francisco Carrillo Padilla, Juan C. Martínez Castrillo, Pilar Sánchez Alonso, Maria G. Alonso Losada, Nuria López Ariztegui, Itziar Gastón, Jaime Kulisevsky, Marta Blázquez Estrada, Manuel Seijo, Javier Rúiz Martínez, Caridad Valero, Mónica Kurtis, Oriol de Fábregues, Jessica González Ardura, Ruben Alonso Redondo, Carlos Ordás, Luis M. L. López Díaz, Darrian McAfee, Pablo Martinez-Martin, Pablo Mir, Study Group COPPADIS
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2023/3104425
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832547927310991360
author Diego Santos-García
Teresa de Deus Fonticoba
Carlos Cores Bartolomé
Maria J. Feal Painceiras
Maria Cristina Íñiguez-Alvarado
Silvia Jesús
Maria Teresa Buongiorno
Lluís Planellas
Marina Cosgaya
Juan García Caldentey
Nuria Caballol
Ines Legarda
Jorge Hernández Vara
Iria Cabo
Lydia López Manzanares
Isabel González Aramburu
Maria A. Ávila Rivera
Víctor Gómez Mayordomo
Víctor Nogueira
Víctor Puente
Julio Dotor García-Soto
Carmen Borrué
Berta Solano Vila
María Álvarez Sauco
Lydia Vela
Sonia Escalante
Esther Cubo
Francisco Carrillo Padilla
Juan C. Martínez Castrillo
Pilar Sánchez Alonso
Maria G. Alonso Losada
Nuria López Ariztegui
Itziar Gastón
Jaime Kulisevsky
Marta Blázquez Estrada
Manuel Seijo
Javier Rúiz Martínez
Caridad Valero
Mónica Kurtis
Oriol de Fábregues
Jessica González Ardura
Ruben Alonso Redondo
Carlos Ordás
Luis M. L. López Díaz
Darrian McAfee
Pablo Martinez-Martin
Pablo Mir
Study Group COPPADIS
author_facet Diego Santos-García
Teresa de Deus Fonticoba
Carlos Cores Bartolomé
Maria J. Feal Painceiras
Maria Cristina Íñiguez-Alvarado
Silvia Jesús
Maria Teresa Buongiorno
Lluís Planellas
Marina Cosgaya
Juan García Caldentey
Nuria Caballol
Ines Legarda
Jorge Hernández Vara
Iria Cabo
Lydia López Manzanares
Isabel González Aramburu
Maria A. Ávila Rivera
Víctor Gómez Mayordomo
Víctor Nogueira
Víctor Puente
Julio Dotor García-Soto
Carmen Borrué
Berta Solano Vila
María Álvarez Sauco
Lydia Vela
Sonia Escalante
Esther Cubo
Francisco Carrillo Padilla
Juan C. Martínez Castrillo
Pilar Sánchez Alonso
Maria G. Alonso Losada
Nuria López Ariztegui
Itziar Gastón
Jaime Kulisevsky
Marta Blázquez Estrada
Manuel Seijo
Javier Rúiz Martínez
Caridad Valero
Mónica Kurtis
Oriol de Fábregues
Jessica González Ardura
Ruben Alonso Redondo
Carlos Ordás
Luis M. L. López Díaz
Darrian McAfee
Pablo Martinez-Martin
Pablo Mir
Study Group COPPADIS
author_sort Diego Santos-García
collection DOAJ
description Introduction. Drooling in Parkinson’s disease (PD) is frequent but often goes underrecognized. Our aim was to examine the prevalence of drooling in a PD cohort and compare it with a control group. Specifically, we identified factors associated with drooling and conducted subanalyses in a subgroup of very early PD patients. Patients and Methods. PD patients who were recruited from January 2016 to November 2017 (baseline visit; V0) and evaluated again at a 2-year ± 30-day follow-up (V2) from 35 centers in Spain from the COPPADIS cohort were included in this longitudinal prospective study. Subjects were classified as with or without drooling according to item 19 of the NMSS (Nonmotor Symptoms Scale) at V0, V1 (1-year ± 15 days), and V2 for patients and at V0 and V2 for controls. Results. The frequency of drooling in PD patients was 40.1% (277/691) at V0 (2.4% (5/201) in controls; p < 0.0001), 43.7% (264/604) at V1, and 48.2% (242/502) at V2 (3.2% (4/124) in controls; p < 0.0001), with a period prevalence of 63.6% (306/481). Being older (OR = 1.032; p = 0.012), being male (OR = 2.333; p < 0.0001), having greater nonmotor symptom (NMS) burden at the baseline (NMSS total score at V0; OR = 1.020; p < 0.0001), and having a greater increase in the NMS burden from V0 to V2 (change in the NMSS total score from V0 to V2; OR = 1.012; p < 0.0001) were identified as independent predictors of drooling after the 2-year follow-up. Similar results were observed in the group of patients with ≤2 years since symptom onset, with a cumulative prevalence of 64.6% and a higher score on the UPDRS-III at V0 (OR = 1.121; p = 0.007) as a predictor of drooling at V2. Conclusion. Drooling is frequent in PD patients even at the initial onset of the disease and is associated with a greater motor severity and NMS burden.
format Article
id doaj-art-81cf020ff63443259403ed892b65e659
institution Kabale University
issn 2042-0080
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-81cf020ff63443259403ed892b65e6592025-02-03T06:42:51ZengWileyParkinson's Disease2042-00802023-01-01202310.1155/2023/3104425Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control GroupDiego Santos-García0Teresa de Deus Fonticoba1Carlos Cores Bartolomé2Maria J. Feal Painceiras3Maria Cristina Íñiguez-Alvarado4Silvia Jesús5Maria Teresa Buongiorno6Lluís Planellas7Marina Cosgaya8Juan García Caldentey9Nuria Caballol10Ines Legarda11Jorge Hernández Vara12Iria Cabo13Lydia López Manzanares14Isabel González Aramburu15Maria A. Ávila Rivera16Víctor Gómez Mayordomo17Víctor Nogueira18Víctor Puente19Julio Dotor García-Soto20Carmen Borrué21Berta Solano Vila22María Álvarez Sauco23Lydia Vela24Sonia Escalante25Esther Cubo26Francisco Carrillo Padilla27Juan C. Martínez Castrillo28Pilar Sánchez Alonso29Maria G. Alonso Losada30Nuria López Ariztegui31Itziar Gastón32Jaime Kulisevsky33Marta Blázquez Estrada34Manuel Seijo35Javier Rúiz Martínez36Caridad Valero37Mónica Kurtis38Oriol de Fábregues39Jessica González Ardura40Ruben Alonso Redondo41Carlos Ordás42Luis M. L. López Díaz43Darrian McAfee44Pablo Martinez-Martin45Pablo Mir46Study Group COPPADIS47CHUAC,Complejo Hospitalario Universitario de A CoruñaCHUF,Complejo Hospitalario Universitario de FerrolCHUAC,Complejo Hospitalario Universitario de A CoruñaCHUAC,Complejo Hospitalario Universitario de A CoruñaCHUAC,Complejo Hospitalario Universitario de A CoruñaUnidad de Trastornos del MovimientoHospital Universitari Mutua de TerrassaClínica del PilarHospital Clínic de BarcelonaCentro Neurológico Oms 42Consorci Sanitari IntegralHospital Universitario Son EspasesHospital Universitario Vall d’HebronComplejo Hospitalario Universitario de Pontevedra (CHOP)Hospital Universitario La PrincesaHospital Universitario Marqués de ValdecillaConsorci Sanitari IntegralHospital Universitario Clínico San CarlosHospital Da CostaHospital del MarHospital Universitario Virgen MacarenaHospital Infanta SofíaInstitut d’Assistència Sanitària (IAS)Hospital General Universitario de ElcheFundación Hospital de AlcorcónHospital de Tortosa Verge de La Cinta (HTVC)Complejo Asistencial Universitario de BurgosHospital Universitario de CanariasHospital Universitario Ramón y CajalHospital Universitario Puerta de HierroHospital Álvaro CunqueiroComplejo Hospitalario de ToledoComplejo Hospitalario de NavarraHospital de Sant PauHospital Universitario Central de AsturiasComplejo Hospitalario Universitario de Pontevedra (CHOP)Hospital Universitario DonostiaHospital Arnau de VilanovaHospital Ruber InternacionalHospital Universitario Vall d’HebronHospital de CabueñesUniversitario Lucus Augusti (HULA)Hospital Rey Juan CarlosComplejo Hospitalario Universitario de Orense (CHUO)University of Maryland School of MedicineCIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas)Unidad de Trastornos del MovimientoFundación DegenIntroduction. Drooling in Parkinson’s disease (PD) is frequent but often goes underrecognized. Our aim was to examine the prevalence of drooling in a PD cohort and compare it with a control group. Specifically, we identified factors associated with drooling and conducted subanalyses in a subgroup of very early PD patients. Patients and Methods. PD patients who were recruited from January 2016 to November 2017 (baseline visit; V0) and evaluated again at a 2-year ± 30-day follow-up (V2) from 35 centers in Spain from the COPPADIS cohort were included in this longitudinal prospective study. Subjects were classified as with or without drooling according to item 19 of the NMSS (Nonmotor Symptoms Scale) at V0, V1 (1-year ± 15 days), and V2 for patients and at V0 and V2 for controls. Results. The frequency of drooling in PD patients was 40.1% (277/691) at V0 (2.4% (5/201) in controls; p < 0.0001), 43.7% (264/604) at V1, and 48.2% (242/502) at V2 (3.2% (4/124) in controls; p < 0.0001), with a period prevalence of 63.6% (306/481). Being older (OR = 1.032; p = 0.012), being male (OR = 2.333; p < 0.0001), having greater nonmotor symptom (NMS) burden at the baseline (NMSS total score at V0; OR = 1.020; p < 0.0001), and having a greater increase in the NMS burden from V0 to V2 (change in the NMSS total score from V0 to V2; OR = 1.012; p < 0.0001) were identified as independent predictors of drooling after the 2-year follow-up. Similar results were observed in the group of patients with ≤2 years since symptom onset, with a cumulative prevalence of 64.6% and a higher score on the UPDRS-III at V0 (OR = 1.121; p = 0.007) as a predictor of drooling at V2. Conclusion. Drooling is frequent in PD patients even at the initial onset of the disease and is associated with a greater motor severity and NMS burden.http://dx.doi.org/10.1155/2023/3104425
spellingShingle Diego Santos-García
Teresa de Deus Fonticoba
Carlos Cores Bartolomé
Maria J. Feal Painceiras
Maria Cristina Íñiguez-Alvarado
Silvia Jesús
Maria Teresa Buongiorno
Lluís Planellas
Marina Cosgaya
Juan García Caldentey
Nuria Caballol
Ines Legarda
Jorge Hernández Vara
Iria Cabo
Lydia López Manzanares
Isabel González Aramburu
Maria A. Ávila Rivera
Víctor Gómez Mayordomo
Víctor Nogueira
Víctor Puente
Julio Dotor García-Soto
Carmen Borrué
Berta Solano Vila
María Álvarez Sauco
Lydia Vela
Sonia Escalante
Esther Cubo
Francisco Carrillo Padilla
Juan C. Martínez Castrillo
Pilar Sánchez Alonso
Maria G. Alonso Losada
Nuria López Ariztegui
Itziar Gastón
Jaime Kulisevsky
Marta Blázquez Estrada
Manuel Seijo
Javier Rúiz Martínez
Caridad Valero
Mónica Kurtis
Oriol de Fábregues
Jessica González Ardura
Ruben Alonso Redondo
Carlos Ordás
Luis M. L. López Díaz
Darrian McAfee
Pablo Martinez-Martin
Pablo Mir
Study Group COPPADIS
Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
Parkinson's Disease
title Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
title_full Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
title_fullStr Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
title_full_unstemmed Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
title_short Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
title_sort prevalence and factors associated with drooling in parkinson s disease results from a longitudinal prospective cohort and comparison with a control group
url http://dx.doi.org/10.1155/2023/3104425
work_keys_str_mv AT diegosantosgarcia prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT teresadedeusfonticoba prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT carloscoresbartolome prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT mariajfealpainceiras prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT mariacristinainiguezalvarado prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT silviajesus prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT mariateresabuongiorno prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT lluisplanellas prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT marinacosgaya prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT juangarciacaldentey prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT nuriacaballol prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT ineslegarda prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT jorgehernandezvara prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT iriacabo prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT lydialopezmanzanares prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT isabelgonzalezaramburu prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT mariaaavilarivera prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT victorgomezmayordomo prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT victornogueira prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT victorpuente prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT juliodotorgarciasoto prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT carmenborrue prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT bertasolanovila prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT mariaalvarezsauco prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT lydiavela prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT soniaescalante prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT esthercubo prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT franciscocarrillopadilla prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT juancmartinezcastrillo prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT pilarsanchezalonso prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT mariagalonsolosada prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT nurialopezariztegui prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT itziargaston prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT jaimekulisevsky prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT martablazquezestrada prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT manuelseijo prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT javierruizmartinez prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT caridadvalero prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT monicakurtis prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT orioldefabregues prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT jessicagonzalezardura prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT rubenalonsoredondo prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT carlosordas prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT luismllopezdiaz prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT darrianmcafee prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT pablomartinezmartin prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT pablomir prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup
AT studygroupcoppadis prevalenceandfactorsassociatedwithdroolinginparkinsonsdiseaseresultsfromalongitudinalprospectivecohortandcomparisonwithacontrolgroup